This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Genmab A+s. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Theodorus Sjouke Plantinga: Innovator in Antibody Development
Introduction
Theodorus Sjouke Plantinga is a notable inventor based in Duiven, Netherlands. He has made significant contributions to the field of biotechnology, particularly in the development of multispecific antibodies. His work is crucial for advancing therapeutic options in cancer treatment.
Latest Patents
Plantinga holds a patent for "Antibodies binding to fibroblast activation protein alpha and death receptor 4." This invention relates to a multispecific antibody that includes a FAPα binding region and a DR4 binding region. The patent outlines pharmaceutical compositions that utilize these antibodies for therapeutic and diagnostic procedures, especially in cancer therapy. He has 1 patent to his name.
Career Highlights
Theodorus Sjouke Plantinga is associated with Genmab AS, a leading biotechnology company focused on developing differentiated antibody therapeutics for the treatment of cancer. His role at Genmab has allowed him to contribute to groundbreaking research and development in the field.
Collaborations
Some of his notable coworkers include Bart Ecg De Goeij and Ilse Jongerius. Their collaborative efforts have further enhanced the innovative work being done at Genmab.
Conclusion
Theodorus Sjouke Plantinga's contributions to antibody development represent a significant advancement in cancer therapy. His innovative work continues to impact the field of biotechnology positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile